• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Aimei Health Technology Co. Ltd

    4/8/25 5:38:58 PM ET
    $AFJK
    Get the next $AFJK alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    Aimei Health Technology Co., Ltd

    (Name of Issuer)


    Ordinary Shares, par value $0.0001 per share

    (Title of Class of Securities)


    G01341109

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    G01341109


    1Names of Reporting Persons

    W. R. Berkley Corporation
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    343,599.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    343,599.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    343,599.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.6 %
    12Type of Reporting Person (See Instructions)

    CO


    SCHEDULE 13G

    CUSIP No.
    G01341109


    1Names of Reporting Persons

    Berkley Insurance Company
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    343,599.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    343,599.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    343,599.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.6 %
    12Type of Reporting Person (See Instructions)

    CO, IC


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Aimei Health Technology Co., Ltd
    (b)Address of issuer's principal executive offices:

    10 East 53rd Street, Suite 3001, New York, New York, 10022
    Item 2. 
    (a)Name of person filing:

    The information required by Item 2(a) is set forth in Row 1 of the cover page hereto for each Reporting Person and is incorporated herein by reference for each such Reporting Person.
    (b)Address or principal business office or, if none, residence:

    The address of each Reporting Person is: 475 Steamboat Road Greenwich, CT 06830
    (c)Citizenship:

    The information required by Item 2(c) is set forth in Row 4 of the cover page hereto for each Reporting Person and is incorporated herein by reference for each such Reporting Person.
    (d)Title of class of securities:

    Ordinary Shares, par value $0.0001 per share
    (e)CUSIP No.:

    G01341109
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page hereto for each Reporting Person and is incorporated herein by reference for each such Reporting Person.
    (b)Percent of class:

    Calculation of the ownership percentage set forth in Row 11 is based on Issuer's publicly available Form 10-K filed April 1, 2025, which states that Issuer had 6,470,000 Class A ordinary shares outstanding as of March 31, 2025 - 5.6
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    0

     (ii) Shared power to vote or to direct the vote:

    343,599

     (iii) Sole power to dispose or to direct the disposition of:

    0

     (iv) Shared power to dispose or to direct the disposition of:

    343,599

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    See Exhibit 99.1.
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    W. R. Berkley Corporation
     
    Signature:/s/ Richard M. Baio
    Name/Title:Richard M. Baio, Executive Vice President and Chief Financial Officer
    Date:04/08/2025
     
    Berkley Insurance Company
     
    Signature:/s/ Richard M. Baio
    Name/Title:Richard M. Baio, Executive Vice President and Treasurer
    Date:04/08/2025
    Get the next $AFJK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AFJK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AFJK
    SEC Filings

    See more
    • Aimei Health Technology Co. Ltd filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)

      6/6/25 8:00:54 AM ET
      $AFJK
    • SEC Form 10-Q filed by Aimei Health Technology Co. Ltd

      10-Q - Aimei Health Technology Co., Ltd. (0001979005) (Filer)

      5/14/25 4:45:19 PM ET
      $AFJK
    • Amendment: SEC Form SCHEDULE 13G/A filed by Aimei Health Technology Co. Ltd

      SCHEDULE 13G/A - Aimei Health Technology Co., Ltd. (0001979005) (Subject)

      5/13/25 6:45:56 AM ET
      $AFJK

    $AFJK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • United Hydrogen Group Inc., a Comprehensive Hydrogen Solution Company in China, Announces Execution of Business Combination Agreement with Aimei Health Technology Co., Ltd to Become a Publicly Traded Company on Nasdaq

       ●United Hydrogen Group Inc. is a comprehensive hydrogen solution company covering hydrogen energy producing, storage and transportation, hydrogen equipment, and hydrogen logistic applications, helping clients fulfill their zero carbon business targets.    ●United Hydrogen Group Inc. generated revenue of approximately US$13.1 million in 2023 (unaudited). Revenue in 2023 increased by 144% compared to revenue in 2022.    ●The proposed transaction values the combined company at an estimated enterprise value on a pro-forma basis of approximately US$1.6 billion, assuming no redemptions by Aimei Health Technology Co., Ltd's shareholders.    Shanghai, China, June 20, 2024 (GLOBE NEWSWIRE) -- Unit

      6/20/24 7:00:00 AM ET
      $AFJK

    $AFJK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Mizuho Securities Usa Llc sold $1,629,000 worth of shares (150,000 units at $10.86), decreasing direct ownership by 21% to 550,387 units (SEC Form 4)

      4 - Aimei Health Technology Co., Ltd. (0001979005) (Issuer)

      2/11/25 2:52:51 PM ET
      $AFJK
    • New insider Mizuho Securities Usa Llc claimed ownership of 700,387 shares (SEC Form 3)

      3 - Aimei Health Technology Co., Ltd. (0001979005) (Issuer)

      2/11/25 2:47:37 PM ET
      $AFJK

    $AFJK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Aimei Health Technology Co. Ltd

      SC 13G/A - Aimei Health Technology Co., Ltd. (0001979005) (Subject)

      11/14/24 5:52:48 PM ET
      $AFJK
    • SEC Form SC 13G filed by Aimei Health Technology Co. Ltd

      SC 13G - Aimei Health Technology Co., Ltd. (0001979005) (Subject)

      11/14/24 1:54:33 PM ET
      $AFJK
    • Amendment: SEC Form SC 13G/A filed by Aimei Health Technology Co. Ltd

      SC 13G/A - Aimei Health Technology Co., Ltd. (0001979005) (Subject)

      11/13/24 4:00:31 PM ET
      $AFJK